1h Free Analyst Time
The global heart attack diagnostics market is forecasted to grow by USD 6.06 billion during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global heart attack diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiac disorders, high adoption of heart rate tracking devices, presence of health awareness programs.
The study identifies the new product launches coupled with research and development activities as one of the prime reasons driving the global heart attack diagnostics market growth during the next few years. Also, growing presence of oems and increasing number of mergers and acquisitions will lead to sizable demand in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global heart attack diagnostics market is segmented as below:
By End-User
- Hospitals
- Ambulatory surgical centers
- Diagnostic centers
- Others
By Test
- Non-invasive tests
- Minimally invasive tests
By Product Type
- Electrocardiogram
- Blood tests
- Echocardiogram
- Angiogram and cardiac catheterization
- Others
By Region
- North America
- Europe
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report covers the following areas:
- Global heart attack diagnostics market sizing
- Global heart attack diagnostics market forecast
- Global heart attack diagnostics market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Test
10 Market Segmentation by Product Type
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global global heart attack diagnostics market: Abbott Laboratories, ACS Diagnostics Inc., Asahi Kasei Corp., AstraZeneca Plc, Beckman Coulter Inc., Bio Rad Laboratories Inc., Boston Scientific Corp., Canon Inc., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., GE Healthcare Technologies, Hill Rom Holdings Inc., Hitachi Ltd., KNOTEN Weimar GmbH iL, Koninklijke Philips NV, Midmark Corp., Nihon Kohden Corp., SCHILLER AG, Siemens Healthineers AG, Toshiba Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is new product launches coupled with research and development activities."
According to the report, one of the major drivers for this market is the rising prevalence of cardiac disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACS Diagnostics Inc.
- Asahi Kasei Corp.
- AstraZeneca PLC
- Beckman Coulter Inc.
- Bio Rad Laboratories Inc.
- Boston Scientific Corp.
- Canon Inc.
- F. Hoffmann La Roche Ltd.
- FUJIFILM Holdings Corp.
- GE Healthcare Technologies
- Hill Rom Holdings Inc.
- Hitachi Ltd.
- KNOTEN Weimar GmbH iL
- Koninklijke Philips NV
- Midmark Corp.
- Nihon Kohden Corp.
- SCHILLER AG
- Siemens Healthineers AG
- Toshiba Corp.
